RxSight (RXST) Gross Profit (2020 - 2026)

RxSight's Gross Profit history runs 7 years deep, the most recent figure standing at $23.5 million for Q1 2026.

• Quarterly Gross Profit fell 17.05% year-over-year to $23.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $98.2 million (down 7.89% YoY) and the FY2025 annual result came in at $103.0 million, up 4.11% from the prior year.
• Gross Profit was $23.5 million for Q1 2026 at RxSight, down from $25.3 million in the prior quarter.
• Across five years, Gross Profit topped out at $28.8 million in Q4 2024 and bottomed at $3.8 million in Q1 2022.
• A 5-year average of $17.7 million and a median of $20.7 million in 2024 frame the typical range for Gross Profit.
• Annual changes were most pronounced in 2022 — Gross Profit surged 689.66% — and 2026, when it declined 17.05%.
• RxSight's Gross Profit stood at $7.4 million in 2022, then soared by 137.86% to $17.7 million in 2023, then jumped by 63.07% to $28.8 million in 2024, then slipped by 12.24% to $25.3 million in 2025, then declined by 6.99% to $23.5 million in 2026.
• Business Quant data shows RXST's Gross Profit at $23.5 million in Q1 2026, $25.3 million in Q4 2025, and $24.2 million in Q3 2025.